TY - JOUR
T1 - Atypical progeroid syndrome and partial lipodystrophy due to LMNA gene p.R349W mutation
AU - Magno, Silvia
AU - Ceccarini, Giovanni
AU - Pelosini, Caterina
AU - Ferrari, Federica
AU - Prodam, Flavia
AU - Gilio, Donatella
AU - Maffei, Margherita
AU - Sessa, Maria Rita
AU - Barison, Andrea
AU - Ciccarone, Annamaria
AU - Emdin, Michele
AU - Aimaretti, Gianluca
AU - Santini, Ferruccio
N1 - Publisher Copyright:
© Endocrine Society 2020.
PY - 2020/10/1
Y1 - 2020/10/1
N2 - Atypical progeroid syndrome (APS) comprises heterogeneous disorders characterized by variable degrees of fat loss, metabolic alterations, and comorbidities that affect skeleton, muscles, and/or the heart. We describe 3 patients that were referred to our center for the suspicion of lipodystrophy. They had precocious aging traits such as short stature, mandibular hypoplasia, beaked nose, and partial alopecia manifesting around 10 to 15 years of age recurrently associated with: (1) partial lipodystrophy; (2) proteinuric nephropathy; (3) heart disease (rhythm disorders, valvular abnormalities, and cardiomyopathy); and (4) sensorineural hearing impairment. In all patients, genetic testing revealed a missense heterozygous lamin A/C gene (LMNA) mutation c.1045 C > T (p.Arg349Trp). Ten patients with LMNA p.R349W mutation have been reported so far, all presenting with similar features, which represent the key pathological hallmarks of this subtype of APS. The associated kidney and cardiac complications occurring in the natural history of the disease may reduce life expectancy. Therefore, in these patients a careful and periodic cardiac and kidney function evaluation is required.
AB - Atypical progeroid syndrome (APS) comprises heterogeneous disorders characterized by variable degrees of fat loss, metabolic alterations, and comorbidities that affect skeleton, muscles, and/or the heart. We describe 3 patients that were referred to our center for the suspicion of lipodystrophy. They had precocious aging traits such as short stature, mandibular hypoplasia, beaked nose, and partial alopecia manifesting around 10 to 15 years of age recurrently associated with: (1) partial lipodystrophy; (2) proteinuric nephropathy; (3) heart disease (rhythm disorders, valvular abnormalities, and cardiomyopathy); and (4) sensorineural hearing impairment. In all patients, genetic testing revealed a missense heterozygous lamin A/C gene (LMNA) mutation c.1045 C > T (p.Arg349Trp). Ten patients with LMNA p.R349W mutation have been reported so far, all presenting with similar features, which represent the key pathological hallmarks of this subtype of APS. The associated kidney and cardiac complications occurring in the natural history of the disease may reduce life expectancy. Therefore, in these patients a careful and periodic cardiac and kidney function evaluation is required.
KW - Atypical progeroid syndrome
KW - LMNA mutation
KW - Lipodystrophy
UR - https://www.scopus.com/pages/publications/85096472639
U2 - 10.1210/jendso/bvaa108
DO - 10.1210/jendso/bvaa108
M3 - Article
SN - 2472-1972
VL - 4
JO - Journal of the Endocrine Society
JF - Journal of the Endocrine Society
IS - 10
ER -